Clinical and microbiological features of definite Mycobacterium gordonae pulmonary disease: The establishment of diagnostic criteria for low-virulence mycobacteria

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 109, Issue 9, 2015, Pages 589-593

  Morimotoa, Kozo ^a,b   Kazumib, Yuko ^b   Shiraishia, Yuji ^a   Yoshiyamaa, Takashi ^a   Muraseb, Yoshiro ^b   Ikushimac, Soichiro ^c   Kurashimaa, Atsuyuki ^a   Kudoha, Shoji ^a   Gotoa, Hajime ^a   Maedab, Shinji ^b  

^a Japan Anti Tuberculosis Association   (Japan)

^b RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Contamination; Mycobacteria Growth Indicator Tube; Mycobacterium gordonae; RpoB sequence

Indexed keywords

BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BRONCHIECTASIS; CENTRIFUGE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DYSPNEA; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROINTESTINAL SYMPTOM; GENETIC IDENTIFICATION; GENOTYPE; HEMOPTYSIS; HUMAN; HUMAN TISSUE; LUNG AUSCULTATION; LUNG DISEASE; MALE; MEDICAL HISTORY; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIA GROWTH INDICATOR TUBE TEST; MYCOBACTERIOSIS; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM TUBERCULOSIS; RELAPSE; SEQUENCE ANALYSIS; SPUTUM SMEAR; STOMACH CANCER; THORAX PAIN; THORAX RADIOGRAPHY; TISSUE CULTURE; ATYPICAL MYCOBACTERIUM; CASE REPORT; ISOLATION AND PURIFICATION; LUNG DISEASES; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS;

AGED; BACTERIOLOGICAL TECHNIQUES; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA;

EID: 84944058967     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trv058     Document Type: Article

References (15)

1. Bojalil LF, Cerbon J, Trujillo A. Adansonian classification of mycobacteria. J Gen Microbiol 1962;28:333-46.
2. HoefslootW, van Ingen J, Andrejak C et al. Nontuberculous Mycobacteria Network European Trials Group. The geographic diversity of nontuberculousmycobacteria isolated from pulmonary samples: an NTM-NETcollaborative study. Eur Respir J 2013;42:1604-13.
3. Arnow PM, Bakir M, Thompson K, Bova JL. Endemic contamination of clinical specimens by Mycobacterium gordonae. Clin Infect Dis 2000;31:472-6.
4. Griffith DE, Aksamit T, Brown-Elliott BA et al.; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007 15;175:367-416.
5. Aguado JM, Gómez-Garcés JL, Manrique A, Soriano F. Pulmonary infection by Mycobacterium gordonae in an immunocompromised patient. Diagn Microbiol Infect Dis 1987;7:261-3.
6. Weinberger M, Berg SL, Feuerstein IM et al. Disseminated infection with Mycobacterium gordonae: report of a case and critical review of the literature. Clin Infect Dis 1992;14:1229-39.
7. Chang CT, Wang LY, Liao CY, Huang SP. Identification of nontuberculous mycobacteria existing in tap water by PCR-restriction fragment length polymorphism. Appl Environ Microbiol 2002;68:3159-61.
8. Kim BJ, Lee SH, Lyu MA et al. Identification ofmycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol 1999;37:1714-20.
9. Itoh S, Kazumi Y, Abe C, Takahashi M. Heterogeneity of RNA polymerase gene (rpoB) sequences of Mycobacterium gordonae clinical isolates identified with a DNA probe kit and by conventional methods. J Clin Microbiol 2003;41:1656-63.
10. Diacon AH, Maritz JS, Venter A et al. Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents. Clin Microbiol Infect 2012;18:711-7.
11. Shin SJ, Han JH, Manning EJ, Collins MT. Rapid and reliable method for quantification of Mycobacterium paratuberculosis by use of the BACTEC 960 system. J Clin Microbiol 2007;45:1941-8
12. Shin SJ, Choi GE, Cho SN et al. Mycobacterial genotypes are associated with clinical manifestation and progression of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense. Clin Infect Dis 2013;57:32-9.
13. Thomson R, Tolson C, Huygens F, Hargreaves M. Strain variation amongst clinical and potable water isolates of M. kansasii using automated repetitive unit PCR. Int J Med Microbiol 2014;304: 484-9.
14. de Zwaan R, van Ingen J, van Soolingen D. Utility of rpoB gene sequencing for identification of nontuberculous mycobacteria in the Netherlands. J Clin Microbiol 2014;52:2544-51.
15. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997;156:S1-25